NCT04489004View on ClinicalTrials.gov

The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation.

NACompletedINTERVENTIONAL
Enrollment

1,298

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2022

Conditions
Atrial Fibrillation, Persistent
Interventions
PROCEDURE

Driver ablation+CPVI

Patients receive driver ablation and CPVI (circumferential pulmonary vein isolation).

PROCEDURE

Stepwise ablation

Patients receive stepwise ablation.

Trial Locations (1)

Unknown

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER

NCT04489004 - The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation. | Biotech Hunter | Biotech Hunter